Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from David Ricks

Gen Z graduates who majored in ‘AI-proof’ careers like pharmacy, biology, and education are making less than $50,000 after graduation

Gen Z workers are flocking to industries like healthcare and education in hopes of evading AI and recessionary impacts—but some of those jobs pay rock-bottom salaries.

Fortune

Tech giants see a cure for cancer in AI. But Eli Lilly’s CEO finds it ‘not particularly good’ at solving biology or chemistry problems

Eli Lilly CEO David Ricks said AI can’t quite solve complex scientific problems without advanced data.

Fortune

The 7 most overlooked CEOs in 2025—and the 5 to watch in 2026

The Yale Chief Executive Leadership Institute highlights the top performers of 2025 and the top leaders to watch in 2026.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill

Eli Lilly CEO David Ricks has announced a new $6 billion manufacturing plant in Alabama dedicated to producing the company's next-generation obesity pill. The move signals Lilly's aggressive expansion as global demand for weight-loss drugs soars.

International Business Times UK

What's Up With The Rise In Eli Lilly Stock Today?

Eli Lilly and Company (NYSE:LLY) shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion for oral medicine.

Benzinga

This Blue-Chip Stock Is Cooking Up a Major Growth Catalyst

Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.

Barchart

Eli Lilly Stock Rises After Profit, Outlook Top Expectations

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 guidance. Here's what you need to know.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly’s CEO pinpoints the 3-pronged problem big execs face with remote work

Managing a distributed workforce is “the leadership challenge of our decade,” David Ricks, CEO of pharma giant Eli Lilly, said.

Fortune

‘Hero’ journalist congratulated after Eli Lilly lowers price of insulin after his spoof tweet raised awareness

Eli Lilly’s CEO challenged other pharmaceutical companies to drop insulin prices as well

The Independent UK

US drug maker to slash some insulin prices, expand cost cap

President Joe Biden hails move by Eli Lilly as a ‘big deal’, calling on other manufacturers to also reduce prices.

Al Jazeera

Eli Lilly plans to slash prices of some older insulins, expand cost cap

Lawmakers and patient advocates have been pressuring drugmakers to take action on soaring drug prices.

Chicago Sun-Times

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.